Research Site — New Brunswick, New Jersey

Research Site is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Research Site has participated in 50 clinical trials with 16 currently active.

Therapeutic areas: Advanced Breast Cancer, Heart Failure With Reduced Ejection Fraction (HFrEF), Uterine Serous Carcinoma.

Sponsors: AstraZeneca, Amgen, Knopp Biosciences.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 50 clinical trials on record, with 16 currently active. Their work covers Advanced Breast Cancer, Heart Failure With Reduced Ejection Fraction (HFrEF), Uterine Serous Carcinoma.

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.